CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients.

CYP2D6 Genotype Should Not Be Used to Determine Endocrine Therapy in Postmenopausal Breast Cancer Patients. Clin Pharmacol Ther. 2013 Aug;94(2):183-5 Authors: Rae JM PMID: 23872830 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23872830?dopt=Abstract

Source: Clinical Breast Cancer - July 24, 2013 Category: Cancer & Oncology Authors: Rae JM Tags: Clin Pharmacol Ther Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy